Literature DB >> 7295728

Influence of local and neutral anaesthetics on the polymorphic phase preferences of egg yolk phosphatidylethanolamine.

A P Hornby, P R Cullis.   

Abstract

(1) The polymorphic phase preferences of egg phosphatidylethanolamine have been examined in the presence of normal alcohols and alkanes of varying chain length, as well as charged amine anaesthetics. (2) It is shown that the charged anaesthetics, ethanol and butanol can stabilize a bilayer arrangement for egg phosphatidylethanolamine. In contrast, longer chain (C greater than or equal to 6) normal alcohols and alkanes induce the hexagonal (HII) phase. (3) The relative potency of local anaesthetics in vitro (chlorpromazine, dibucaine, tetracaine and procaine) is mirrored by their relative ability to stabilize bilayer structure for hydrated egg phosphatidylethanolamine. Further, the aqueous concentrations of anaesthetic required to affect phospholipid polymorphism is sensitive to the lipid composition. For example, the inclusion of 20 mol% egg phosphatidylserine in egg phosphatidylethanolamine dispersions can reduce the aqueous concentrations of dibucaine required to induce appreciable bilayer stabilization effects from 5.0 mM to 0.5 mM. (4) It is suggested that the ability of amphipathic molecules such as anaesthetics to influence phosphatidylethanolamine polymorphism arises from their molecular shape. The possibility that anaesthetic molecules may exert their effects by virtue of this shape property is raised.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295728     DOI: 10.1016/0005-2736(81)90256-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

Review 1.  Chemical shift tensor - the heart of NMR: Insights into biological aspects of proteins.

Authors:  Hazime Saitô; Isao Ando; Ayyalusamy Ramamoorthy
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2010-05-07       Impact factor: 9.795

2.  Hydrophobic molecules in lecithin-water systems. I. Formation of reversed hexagonal phases at high and low water contents.

Authors:  M Sjölund; G Lindblom; L Rilfors; G Arvidson
Journal:  Biophys J       Date:  1987-08       Impact factor: 4.033

3.  Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion.

Authors:  G B Melikyan; S A Brener; D C Ok; F S Cohen
Journal:  J Cell Biol       Date:  1997-03-10       Impact factor: 10.539

4.  Conformation of the C1 phorbol-ester-binding domain participates in the activating conformational change of protein kinase C.

Authors:  C Ho; S J Slater; B A Stagliano; C D Stubbs
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

5.  Alcohol's effects on lipid bilayer properties.

Authors:  Helgi I Ingólfsson; Olaf S Andersen
Journal:  Biophys J       Date:  2011-08-17       Impact factor: 4.033

6.  Effects of solvents and alcohols on the polar lipid composition of Clostridium butyricum under conditions of controlled lipid chain composition.

Authors:  D L MacDonald; H Goldfine
Journal:  Appl Environ Microbiol       Date:  1991-12       Impact factor: 4.792

7.  Triggering Glutamate Excretion in Corynebacterium glutamicum by Modulating the Membrane State with Local Anesthetics and Osmotic Gradients.

Authors:  C Lambert; A Erdmann; M Eikmanns; R Kramer
Journal:  Appl Environ Microbiol       Date:  1995-12       Impact factor: 4.792

8.  Interaction of chlorpromazine with phospholipid membranes. An EPR study of membrane surface potential effects.

Authors:  C Anteneodo; P M Bisch; J F Marques
Journal:  Eur Biophys J       Date:  1995       Impact factor: 1.733

9.  Lipidosis-like alterations in cultured macrophages exposed to local anaesthetics.

Authors:  M Jägel; R Lüllmann-Rauch
Journal:  Arch Toxicol       Date:  1984-10       Impact factor: 5.153

10.  Connexin channels and phospholipids: association and modulation.

Authors:  Darren Locke; Andrew L Harris
Journal:  BMC Biol       Date:  2009-08-17       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.